The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Researchers Fight Cellular Senescence, Low-Grade Inflammation

Researchers Fight Cellular Senescence, Low-Grade Inflammation

September 20, 2018 • By Thomas R. Collins

  • Tweet
  • Email
Print-Friendly Version / Save PDF
one photo / shutterstock.com

one photo / shutterstock.com

AMSTERDAM—Low-grade inflammation in older adults can impede immune responsiveness, and researchers have shed light on how this happens. They have developed a short-term treatment that blocks inflammation and boosts the immune response, an expert said at EULAR: the Annual European Congress of Rheumatology.

You Might Also Like
  • Low-Grade Inflammation in Symptomatic Knee OA
  • Researchers Probe the Role of Fat Cells in Inflammation
  • Telomere Length Provides Insights into Cartilage Aging and Repair
Explore This Issue
September 2018
Also By This Author
  • Cancer Risk for Patients with Juvenile Idiopathic Arthritis Taking TNF Inhibitors

The findings were presented in a session on cellular senescence related to inflammation and rheumatic diseases that also included new findings on how targeting a certain protein could help reverse senescence in chondrocytes and help osteoarthritis patients.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Low-Level Inflammation

As people age, inflammation develops at low levels, not as high as that seen in rheumatic diseases, but with effects nonetheless, said Arne Akbar, PhD, professor of immunology at University College London and associate of the Institute of Healthy Aging. This can result in reactivation of viruses that someone had already developed immunity to, such as chickenpox. This immune senescence tends to result from DNA damage caused by reactive oxygen species, ionizing radiation or ultraviolet radiation, Dr. Akbar said.

“Senescence is there to prevent cells with damaged DNA from proliferating,” Dr. Akbar said. If the cells did spread, there would be a risk of malignancy.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

In a second phase, the cell attempts to repair the damage, using a cluster of proteins around damaged areas. If the repairs are made, the cell can go back to its normal functions. But if not, in a third stage, kinases are activated, leading to growth arrest of the damaged cells.

Dr. Akbar

Dr. Akbar

“Senescent cells are not just useless cells that sit around doing nothing,” Dr. Akbar said. “They’re actually quite inflammatory,” bringing on a phenomenon known as inflammaging. “They secrete a whole range of inflammatory mediators, and that’s thought to be because [the body is] trying to get the immune system to come along and eradicate those cells or to get some tissue remodeling associated with damage in those cell types.”

The researchers in the Akbar group have found a clear divide in the response to immune skin challenges between younger and older subjects. But they have found this isn’t due to a lower number of memory T cells, but seems to be because of differences in the skin environment. They have also found the accumulation of senescent fibroblasts in the skin during aging is correlated with lower clinical scores on immune skin challenges.1

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Akbar’s team wondered: Is there a way to block this inflammation and bring about a more robust immune response?

As people age, an inflammation develops at low levels, not as high as tha t seen in rheumatic diseases, but with effects nonetheless, said Arne Akbar, PhD.

Losmapimod Study

In recent work, the researchers injected older adults with varicella zoster vaccine (VZV), measured the immune response and assigned a clinical score.2 Two to three months later, they treated patients with the p38 mitogen-activated protein (MAP) kinase inhibitor losmapimod, followed by another VZV injection four days later, and another clinical score was calculated.

Pages: 1 2 3 | Single Page

Filed Under: Conditions, Osteoarthritis Tagged With: inflammation, knee osteoarthritis, senescence, senescentIssue: September 2018

You Might Also Like:
  • Low-Grade Inflammation in Symptomatic Knee OA
  • Researchers Probe the Role of Fat Cells in Inflammation
  • Telomere Length Provides Insights into Cartilage Aging and Repair
  • Eat to Fight Inflammation & Promote Weight Loss

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)